The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global GMP Plasmid DNA Manufacturing Market Research Report 2024
Synopsis
The global GMP Plasmid DNA Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The growing interest and investment in gene therapy contribute to the demand for GMP plasmid DNA manufacturing. Plasmid DNA is often used as a vector in gene therapy applications.
Technological advancements in biotechnology enhance the efficiency and capabilities of plasmid DNA manufacturing processes, driving the market forward.
This report aims to provide a comprehensive presentation of the global market for GMP Plasmid DNA Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Plasmid DNA Manufacturing.
Report Scope
The GMP Plasmid DNA Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Plasmid DNA Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Plasmid DNA Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Patheon
AGC Biologics
Creative Biolabs
Synbio Technologies
Aldevron
Takara Bio
Recipharm
Eurogentec
Akron Biotech
Catalent Biologics
Xpress Biologics
Esco Aster
Biovian
GenScript ProBio
Andelyn Biosciences
WuXi Advanced Therapies
Waisman Biomanufacturing
GenScript Biotech
Segment by Type
Research Grade Plasmid DNA
Commercial Grade Plasmid DNA
Segment by Application
Cancers
Inherited Disorders
Viral Infections
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Plasmid DNA Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global GMP Plasmid DNA Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The growing interest and investment in gene therapy contribute to the demand for GMP plasmid DNA manufacturing. Plasmid DNA is often used as a vector in gene therapy applications.
Technological advancements in biotechnology enhance the efficiency and capabilities of plasmid DNA manufacturing processes, driving the market forward.
This report aims to provide a comprehensive presentation of the global market for GMP Plasmid DNA Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Plasmid DNA Manufacturing.
Report Scope
The GMP Plasmid DNA Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Plasmid DNA Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Plasmid DNA Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Patheon
AGC Biologics
Creative Biolabs
Synbio Technologies
Aldevron
Takara Bio
Recipharm
Eurogentec
Akron Biotech
Catalent Biologics
Xpress Biologics
Esco Aster
Biovian
GenScript ProBio
Andelyn Biosciences
WuXi Advanced Therapies
Waisman Biomanufacturing
GenScript Biotech
Segment by Type
Research Grade Plasmid DNA
Commercial Grade Plasmid DNA
Segment by Application
Cancers
Inherited Disorders
Viral Infections
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Plasmid DNA Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GMP Plasmid DNA Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Research Grade Plasmid DNA
1.2.3 Commercial Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global GMP Plasmid DNA Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GMP Plasmid DNA Manufacturing Market Perspective (2019-2030)
2.2 GMP Plasmid DNA Manufacturing Growth Trends by Region
2.2.1 Global GMP Plasmid DNA Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 GMP Plasmid DNA Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 GMP Plasmid DNA Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 GMP Plasmid DNA Manufacturing Market Dynamics
2.3.1 GMP Plasmid DNA Manufacturing Industry Trends
2.3.2 GMP Plasmid DNA Manufacturing Market Drivers
2.3.3 GMP Plasmid DNA Manufacturing Market Challenges
2.3.4 GMP Plasmid DNA Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GMP Plasmid DNA Manufacturing Players by Revenue
3.1.1 Global Top GMP Plasmid DNA Manufacturing Players by Revenue (2019-2024)
3.1.2 Global GMP Plasmid DNA Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global GMP Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GMP Plasmid DNA Manufacturing Revenue
3.4 Global GMP Plasmid DNA Manufacturing Market Concentration Ratio
3.4.1 Global GMP Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP Plasmid DNA Manufacturing Revenue in 2023
3.5 GMP Plasmid DNA Manufacturing Key Players Head office and Area Served
3.6 Key Players GMP Plasmid DNA Manufacturing Product Solution and Service
3.7 Date of Enter into GMP Plasmid DNA Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GMP Plasmid DNA Manufacturing Breakdown Data by Type
4.1 Global GMP Plasmid DNA Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global GMP Plasmid DNA Manufacturing Forecasted Market Size by Type (2025-2030)
5 GMP Plasmid DNA Manufacturing Breakdown Data by Application
5.1 Global GMP Plasmid DNA Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global GMP Plasmid DNA Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America GMP Plasmid DNA Manufacturing Market Size (2019-2030)
6.2 North America GMP Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America GMP Plasmid DNA Manufacturing Market Size by Country (2019-2024)
6.4 North America GMP Plasmid DNA Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GMP Plasmid DNA Manufacturing Market Size (2019-2030)
7.2 Europe GMP Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe GMP Plasmid DNA Manufacturing Market Size by Country (2019-2024)
7.4 Europe GMP Plasmid DNA Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GMP Plasmid DNA Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific GMP Plasmid DNA Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific GMP Plasmid DNA Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific GMP Plasmid DNA Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GMP Plasmid DNA Manufacturing Market Size (2019-2030)
9.2 Latin America GMP Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America GMP Plasmid DNA Manufacturing Market Size by Country (2019-2024)
9.4 Latin America GMP Plasmid DNA Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GMP Plasmid DNA Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa GMP Plasmid DNA Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa GMP Plasmid DNA Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa GMP Plasmid DNA Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories GMP Plasmid DNA Manufacturing Introduction
11.1.4 Charles River Laboratories Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 Patheon
11.2.1 Patheon Company Detail
11.2.2 Patheon Business Overview
11.2.3 Patheon GMP Plasmid DNA Manufacturing Introduction
11.2.4 Patheon Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.2.5 Patheon Recent Development
11.3 AGC Biologics
11.3.1 AGC Biologics Company Detail
11.3.2 AGC Biologics Business Overview
11.3.3 AGC Biologics GMP Plasmid DNA Manufacturing Introduction
11.3.4 AGC Biologics Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.3.5 AGC Biologics Recent Development
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Detail
11.4.2 Creative Biolabs Business Overview
11.4.3 Creative Biolabs GMP Plasmid DNA Manufacturing Introduction
11.4.4 Creative Biolabs Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.4.5 Creative Biolabs Recent Development
11.5 Synbio Technologies
11.5.1 Synbio Technologies Company Detail
11.5.2 Synbio Technologies Business Overview
11.5.3 Synbio Technologies GMP Plasmid DNA Manufacturing Introduction
11.5.4 Synbio Technologies Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.5.5 Synbio Technologies Recent Development
11.6 Aldevron
11.6.1 Aldevron Company Detail
11.6.2 Aldevron Business Overview
11.6.3 Aldevron GMP Plasmid DNA Manufacturing Introduction
11.6.4 Aldevron Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.6.5 Aldevron Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio GMP Plasmid DNA Manufacturing Introduction
11.7.4 Takara Bio Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.7.5 Takara Bio Recent Development
11.8 Recipharm
11.8.1 Recipharm Company Detail
11.8.2 Recipharm Business Overview
11.8.3 Recipharm GMP Plasmid DNA Manufacturing Introduction
11.8.4 Recipharm Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.8.5 Recipharm Recent Development
11.9 Eurogentec
11.9.1 Eurogentec Company Detail
11.9.2 Eurogentec Business Overview
11.9.3 Eurogentec GMP Plasmid DNA Manufacturing Introduction
11.9.4 Eurogentec Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.9.5 Eurogentec Recent Development
11.10 Akron Biotech
11.10.1 Akron Biotech Company Detail
11.10.2 Akron Biotech Business Overview
11.10.3 Akron Biotech GMP Plasmid DNA Manufacturing Introduction
11.10.4 Akron Biotech Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.10.5 Akron Biotech Recent Development
11.11 Catalent Biologics
11.11.1 Catalent Biologics Company Detail
11.11.2 Catalent Biologics Business Overview
11.11.3 Catalent Biologics GMP Plasmid DNA Manufacturing Introduction
11.11.4 Catalent Biologics Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.11.5 Catalent Biologics Recent Development
11.12 Xpress Biologics
11.12.1 Xpress Biologics Company Detail
11.12.2 Xpress Biologics Business Overview
11.12.3 Xpress Biologics GMP Plasmid DNA Manufacturing Introduction
11.12.4 Xpress Biologics Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.12.5 Xpress Biologics Recent Development
11.13 Esco Aster
11.13.1 Esco Aster Company Detail
11.13.2 Esco Aster Business Overview
11.13.3 Esco Aster GMP Plasmid DNA Manufacturing Introduction
11.13.4 Esco Aster Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.13.5 Esco Aster Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian GMP Plasmid DNA Manufacturing Introduction
11.14.4 Biovian Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.14.5 Biovian Recent Development
11.15 GenScript ProBio
11.15.1 GenScript ProBio Company Detail
11.15.2 GenScript ProBio Business Overview
11.15.3 GenScript ProBio GMP Plasmid DNA Manufacturing Introduction
11.15.4 GenScript ProBio Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.15.5 GenScript ProBio Recent Development
11.16 Andelyn Biosciences
11.16.1 Andelyn Biosciences Company Detail
11.16.2 Andelyn Biosciences Business Overview
11.16.3 Andelyn Biosciences GMP Plasmid DNA Manufacturing Introduction
11.16.4 Andelyn Biosciences Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.16.5 Andelyn Biosciences Recent Development
11.17 WuXi Advanced Therapies
11.17.1 WuXi Advanced Therapies Company Detail
11.17.2 WuXi Advanced Therapies Business Overview
11.17.3 WuXi Advanced Therapies GMP Plasmid DNA Manufacturing Introduction
11.17.4 WuXi Advanced Therapies Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.17.5 WuXi Advanced Therapies Recent Development
11.18 Waisman Biomanufacturing
11.18.1 Waisman Biomanufacturing Company Detail
11.18.2 Waisman Biomanufacturing Business Overview
11.18.3 Waisman Biomanufacturing GMP Plasmid DNA Manufacturing Introduction
11.18.4 Waisman Biomanufacturing Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.18.5 Waisman Biomanufacturing Recent Development
11.19 GenScript Biotech
11.19.1 GenScript Biotech Company Detail
11.19.2 GenScript Biotech Business Overview
11.19.3 GenScript Biotech GMP Plasmid DNA Manufacturing Introduction
11.19.4 GenScript Biotech Revenue in GMP Plasmid DNA Manufacturing Business (2019-2024)
11.19.5 GenScript Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
